Sp642

UPDATE ON THE MASH THERAPEUTIC PIPELINE: FDA APPROVAL?

Date
May 19, 2024

Presenter


Tracks

Related Products

Thumbnail for INCIDENCE, CLINICAL CHARACTERISTICS AND OUTCOMES ASSOCIATED WITH RECURRENT ALCOHOL ASSOCIATED HEPATITIS: A MULTICENTER STUDY
INCIDENCE, CLINICAL CHARACTERISTICS AND OUTCOMES ASSOCIATED WITH RECURRENT ALCOHOL ASSOCIATED HEPATITIS: A MULTICENTER STUDY
BACKGROUND AND AIMS: Mitochondrial damage-associated molecular patterns(DAMPs) share structural similarity with bacteria and may trigger potent immune response…